Changes of bone mineral density, quantitative ultrasound parameters and markers of bone turnover during treatment of hyperthyroidism

Netherlands Journal of Medicine

Volumn 66, Issue 10, 2008, Pages 428-432

  van de Ven, A C ^a,b   Erdtsieck, R J ^a,b  

^a MÁXIMA MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone mass; Hyperthyroidism; Quantitative ultrasound

Indexed keywords

ALKALINE PHOSPHATASE; LEVOTHYROXINE; PYRIDINOLINE; THIAMAZOLE;

ADULT; ARTICLE; BONE DENSITY; BONE MASS; BONE TURNOVER; CALCANEUS; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG RESPONSE; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; FEMALE; FEMUR NECK; HUMAN; HYPERTHYROIDISM; LUMBAR SPINE; MALE; MONOTHERAPY; PROTEIN URINE LEVEL; QUANTITATIVE ANALYSIS; TREATMENT DURATION;

ADULT; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; FEMALE; HUMANS; HYPERTHYROIDISM; MALE; METHIMAZOLE; MIDDLE AGED; THYROXINE; YOUNG ADULT;

EID: 56749109791     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Von Recklinghausen FD. Die Fibröse oder deforrnierende Ostitis, die Osteomalazie und die osteoplastische Carzinose in ihren gegenseitigen Beziehungen. Festchrift Rudolf Virchow. George Reimer, Berlin 1891:1.
2. Ross DS. Hyperthyroidism, thyroid hormone therapy and bone. Thyroid. 1994;4:319-26.
3. Mundy GR, Shapiro JL, Bandelin JG, Canalis JG, Raisz LG. Direct stimulation of bone resorption by thyroid hormones. J Clin Invest. 1976;58:529-34.
4. Abe E, Marians RC, Yu W, et al. TSH is a negative regulator of skeletal remodeling. Cell. 2003;115:151-62.
5. Lakatos P, Foldes J, Horvath C, et al. Serum interleukin-6 and bone metabolism in patients with thyroid function disorders. J Clin Endocrinol Metab. 1997;82:78-81.
6. Nielsen HE, Mosekilde L, Charles P. Bone mineral content in hyperthyroid patients after combined medical and surgical treatment. Acta Radiol Oncol Radiat Phys Biol. 1979;18:122-8.
7. Linde J, Friis T. Osteoporosis in hyperthyroidism estimated by photon absorptiometry. Acta Endocrinol. 1979;91:437-48.
8. Langdahl BL, Loft AG, Eriksen EF, Mosekilde L, Charles P. Bone mass, bone turnover, body composition, and calcium homeostasis in former hyperthyroid patients treated by combined medical therapy. Thyroid. 1996;6(3):161-8.
9. Karga H, Papapetrou PD, Korakovouni A, Papandroulaki F, Polymeris A, Pampouras G. Bone mineral density in hyperthyroidism. Clin Endocrinol. 2004;61:466-72.
10. Krolner B, Jorgensen JV, Nielsen SP. Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone(s) and antithyroid treatment. Clin Endocrinol. 1983;18:439-46.
11. Diamond T, Vine J, Smart R, Butler P. Thyrotoxic bone disease in women: a potentially reversible disorder. Ann Intern Med. 1994;120:8-11.
12. Toh SH, Claunch BC, Brown PH. Effect of hyperthyroidism and its treatment on bone mineral content. Arch Intern Med. 1985;145:833-86.
13. Rosen CJ, Adler RA. Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. J Clin Endocrinol Metab. 1992;75:1531-4.
14. Jodar E, Munoz-Torres M, Escobar-Jimenez F, Quesada-Charneco M, Luna del Castillo JD. Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: influence of aetiology and menopause. Clin Endocrinology.1997;47:279-86.
15. Acotto CG, Niepomniszcze H, Vega E, Mautalen CA. Ultrasound parameters and markers of bone turnover in hyperthyroidism. J Clin Densitometry. 2004;7(2):201-8.
16. Vestergaard P, Mosekilde L. Hyperthyroidism, bone mineral, and fracture risk-a meta-analysis Thyroid. 2003;13(6):585-93.
17. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence ofosteoporotic fractures. BMJ. 7996;312:1254-9.
18. Khaw KT, Reeve J, Luben R, et al. Prediction of total and hip fracture risk in men and women by quantitative ultrasound of the calcaneus: EPIC-Norfolk prospective population study. Lancet. 2004;363:197-202.
19. Glüer CC. Quantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status. The International Quantitative Ultrasound Consensus Group. J Bone Miner Res. 1997;12(8);1280-8.
20. Njeh CF, Fuerst T, Diessel E, Genant HK. Is quantitative ultrasound dependent on bone structure? A reflection. Osteoporos Int. 2001;12(1):1-15.
21. Van den Bergh JP, Smals AG, Schweitzer DH, Hermus ARMM. Ultrasound measurements of calcaneus: a promising method for predicting of osteoporotic fractures. Ned Tijdschr Geneeskd. 2001;145:05-9.
22. Garnero P, Vassy V, Bertholin A, Riou JP, Delmas PD. Markers of bone turnover in hyperthyroidism and the effects of treatment. J Clin Endocrinol Metab. 1994;78(4):955-9.
23. Isaia GC, Roggia C, Gola D et al. Bone turnover in hyperthyroidism before and after thyrostatic management. J Endocrinol Invest. 2000;23(11):727-31.
24. Akalin A, Colak O, Alatas O, Efe B. Bone remodelling markers and serum cytokines in patients with hyperthyroidism. Clin Endocrinol (Oxf). 2002;57(1):125-9.
25. Acotto CG, Schott AM, Hans D, Niepomniszcze H, Mautalan CA, Meunier PJ. Hyperthyroidism influences ultrasound bone measurement on the os calcis. Osteoporos Int. 1998;8:455-9.